VTE incidence by prophylaxis and diagnosis type | ||||
---|---|---|---|---|
Prophylaxis type | Ultrasound VTE incidence | Venography VTE incidence | Symptomatic VTE incidence | Pulmonary embolism incidence |
LMWH | 16/207, 7.73% | 40/116, 34.48% | 2/141, 1.42% | 1/251, 0.40% |
NOAC | 1/15, 6.67% | 33/152, 21.71% | 1/152, 0.66% | 0/152, 0.00% |
MOP | 42/294, 14.29% | 94/874, 10.76% | 7/802, 0.87% | 2/1896, 0.11% |
NP | 62/659, 9.41% | 83/196, 42.35% | 23/1191, 1.93% | 5/1359, 0.37% |
Statistical analysis | ||||
---|---|---|---|---|
LMWH versus NOAC | p = 0.881 | p = 0.020 | p = 0.516 | p = 0.435 |
LMWH versus MOP | p = 0.024 | p < 0.001 | p = 0.542 | p = 0.242 |
LMWH versus NP | p = 0.460 | p = 0.171 | p = 0.674 | p = 0.944 |
NOAC versus MOP | p = 0.407 | p < 0.001 | p = 0.787 | p = 0.690 |
NOAC versus NP | p = 0.719 | p < 0.001 | p = 0.263 | p = 0.453 |
MOP versus NP | p = 0.026 | p < 0.001 | p = 0.057 | p = 0.254 |